NASDAQ · CLGN
Healthcare · Biotechnology
$4.14
Down-$0.27 (-6.02%)
Updated Nov 2, 2026, 9:05 AM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · CLGN
1M range · 0 trading sessions · Daily adjusted prices
CLGN does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning CLGN.
Company
Market Activity
Research & News
CLGN research
Company profile and research snapshot.
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Feb 6, 2026 | D. Boral Capital | Hold | — |
| Nov 28, 2025 | D. Boral Capital | Buy | — |
| Oct 20, 2025 | D. Boral Capital | Buy | — |
| Sep 16, 2025 | D. Boral Capital | Buy | — |
| Aug 21, 2025 | HC Wainwright & Co. | Buy | — |
No generated briefing is available yet.
Benzinga · Oct 29, 2026
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) today announced that its subsidiary LightSolver Ltd. ("LightSolver"), a pioneer of pure photonic computing and developer of the Laser Processing Unit (LPU)™, has
Yahoo · Oct 29, 2026
The Israel Ministry of Defense Engagement Strengthens LightSolver’s Position in the Emerging Photonic Computing Market for Defense Applications, Estimated at Up to $5 Billion AnnuallyRehovot, Israel, Oct. 29, 2026 (GLOBE NEWSWIRE) -- CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that its subsidiary LightSolver Ltd. ("LightSolver"), a pioneer of pure photonic computing and developer of the Laser Processing Unit (LPU)™, has signed an agreement with the Directorate of Defense Resear
Yahoo · Oct 9, 2026
CollPlant Biotechnologies (Nasdaq: CLGN), an innovative technology company operating at the intersection of deep-tech photonic computing and biotechnology today announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 989,301 of the Company's ordinary shares (or ordinary share equivalents in lieu thereof) and unregistered warrants to purchase up to 1,483,952 ordinary shares in a private placement at a combined purchase price of $3.74 per ordinary shar
Benzinga · Oct 9, 2026
The private placement, which is comprised primarily of the Company's existing investors, reflects confidence in CollPlant's expanded strategic vision and its execution capabilities in deep-tech photonic
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CLGN.
